News
TMDX
121.65
-0.22%
-0.27
TransMedics to Present at J.P. Morgan Healthcare Conference
Reuters · 12/30/2025 21:05
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Barchart · 12/30/2025 15:05
Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More
Benzinga · 12/29/2025 15:31
Weekly Report: what happened at TMDX last week (1222-1226)?
Weekly Report · 12/29/2025 09:53
TransMedics Grants Stock Options and Restricted Stock Units to New Employees
Reuters · 12/24/2025 21:05
TransMedics Group: I Estimate A Large Upside By The End Of 2028
Seeking Alpha · 12/24/2025 05:27
Here's How Much $1000 Invested In TransMedics Group 5 Years Ago Would Be Worth Today
Benzinga · 12/23/2025 22:30
TransMedics: A Stagnant Monopoly Facing Regulatory Pressure
Seeking Alpha · 12/23/2025 14:06
TransMedics Group: Strong Q4 Transplant Volume Momentum and Revenue Upside Support Buy Rating
TipRanks · 12/23/2025 12:16
Alphatec is the top performing healthcare equipment stock YTD
Seeking Alpha · 12/22/2025 17:12
TransMedics Group (TMDX) Gets a Buy from Piper Sandler
TipRanks · 12/22/2025 12:06
Analysts’ Top Healthcare Picks: TransMedics Group (TMDX), Cytokinetics (CYTK)
TipRanks · 12/22/2025 12:00
Weekly Report: what happened at TMDX last week (1215-1219)?
Weekly Report · 12/22/2025 09:53
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026
NASDAQ · 12/18/2025 14:08
TransMedics Group Is Maintained at Buy by Canaccord Genuity
Dow Jones · 12/17/2025 20:19
TransMedics Group Price Target Raised to $148.00/Share From $147.00 by Canaccord Genuity
Dow Jones · 12/17/2025 20:19
Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $148
Benzinga · 12/17/2025 20:10
TransMedics price target raised to $148 from $147 at Canaccord
TipRanks · 12/17/2025 12:25
Analysts Are Bullish on Top Healthcare Stocks: Boston Scientific (BSX), TransMedics Group (TMDX)
TipRanks · 12/16/2025 10:20
Weekly Report: what happened at TMDX last week (1208-1212)?
Weekly Report · 12/15/2025 09:58
More
Webull provides a variety of real-time TMDX stock news. You can receive the latest news about Transmedics Group through multiple platforms. This information may help you make smarter investment decisions.
About TMDX
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.